Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.31 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.30 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14901082 | 0.80 | L3MBTL1 (0.44) | KDM4EATML3MBTL1KMT2APLA2G10 | |
| SCHEMBL14901084 | 0.76 | CYP1A2 (0.41) | KDM4EATML3MBTL1KMT2APLA2G10 | |
| SCHEMBL14901087 | 0.76 | KDM4E (0.40) | KDM4EATML3MBTL1KMT2APLA2G10 | |
| SCHEMBL14901085 | 0.75 | KDM4E (0.39) | KDM4EATML3MBTL1KMT2AMEN1 | |
| SCHEMBL14901090 | 0.75 | KDM4E (0.39) | KDM4EATML3MBTL1KMT2APPARG | |
| SCHEMBL24127584 | 0.70 | L3MBTL1 (0.59) | KDM4EATML3MBTL1KMT2APLA2G10 | |
| SCHEMBL25799362 | 0.70 | L3MBTL1 (0.59) | KDM4EATML3MBTL1KMT2APLA2G10 | |
| SCHEMBL2269282 | 0.68 | KDM4E (0.47) | KDM4EATML3MBTL1KMT2AMEN1 | |
| SCHEMBL29518761 | 0.68 | ATM (0.65) | KDM4EATML3MBTL1KMT2AIL1R1 | |
| SCHEMBL29598680 | 0.68 | ATM (0.65) | KDM4EATML3MBTL1KMT2AIL1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9051266-B2 | Carbazole derivatives and organic light emitting diodes comprising the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2015-06-09 | — | — | US | disclosed |
| US-9051266-B2 | Carbazole derivatives and organic light emitting diodes comprising the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2015-06-09 | — | — | US | disclosed |
| US-20130105767-A1 | CARBAZOLE DERIVATIVES AND ORGANIC LIGHT EMITTING DIODES COMPRISING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-05-02 | — | — | US | disclosed |
| US-20130105767-A1 | CARBAZOLE DERIVATIVES AND ORGANIC LIGHT EMITTING DIODES COMPRISING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130105767-A1 | CARBAZOLE DERIVATIVES AND ORGANIC LIGHT EMITTING DIODES COMPRISING THE SAME | DRD1, DRD3, DOT1L | KDM4E 2187/4885ATM 1479/4885L3MBTL1 52/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.